Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : RSLS    save search

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
Published: 2024-03-28 (Crawled : 12:30) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: 5.08% H: 3.99% C: -3.15%

lifesciences patent system
ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
Published: 2024-03-04 (Crawled : 13:30) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: -6.9% H: 6.86% C: 1.24%

lifesciences update commercialization
ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
Published: 2024-02-22 (Crawled : 13:30) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: 0.18% H: 1.74% C: -4.55%

lifesciences first
ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX
Published: 2024-01-24 (Crawled : 13:30) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: 0.63% H: 0.72% C: -5.77%

lifesciences
ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
Published: 2023-12-20 (Crawled : 13:30) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: 3.46% H: 11.18% C: -5.23%

lifesciences partnership group
ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX
Published: 2023-12-12 (Crawled : 21:00) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: 59.44% H: 47.43% C: -3.95%

lifesciences fda approval
ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds
Published: 2023-11-21 (Crawled : 13:00) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: -6.61% H: 3.02% C: -3.63%

lifesciences
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan
Published: 2023-11-08 (Crawled : 22:00) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: -6.66% H: 5.49% C: -2.7%

lifesciences financial results
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Update
Published: 2023-11-06 (Crawled : 13:30) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: -0.79% H: 0.8% C: -4.96%

lifesciences update financial results
ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering
Published: 2023-09-29 (Crawled : 16:00) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: 11.39% H: 4.47% C: -31.03%

lifesciences offering
ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVI
Published: 2023-09-22 (Crawled : 13:00) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: -0.18% H: 7.34% C: -3.31%

lifesciences
ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System
Published: 2023-09-21 (Crawled : 12:30) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: -0.7% H: 0.07% C: -8.69%

lifesciences license system agreement
ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon System
Published: 2023-09-19 (Crawled : 13:00) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: 2.27% H: 0.47% C: -7.7%

lifesciences patent system
Weight Management Devices Market to grow by USD 4.57 billion between 2022 - 2027 | Growth Driven by Growing obese Population - Technavio
Published: 2023-09-18 (Crawled : 04:00) - prnewswire.com
NOKBF | News | $3.6 -2.55% 400 twitter stocktwits trandingview |
Electronic Technology
| | O: -0.05% H: 1.53% C: -0.2%
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: 0.67% H: 4.0% C: -7.87%
MDT | $80.38 -1.12% 0.0% 5M twitter stocktwits trandingview |
Health Technology
| | O: 0.59% H: 1.69% C: 0.67%
ABBV | News | $167.8 -1.03% -0.06% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 0.0% C: 0.0%
GRMN | $142.79 0.2% 0.0% 610K twitter stocktwits trandingview |
Electronic Technology
| | O: 0.25% H: 1.05% C: 0.63%

management growing growth market
ReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ Device
Published: 2023-09-14 (Crawled : 12:30) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: 1.3% H: 8.44% C: -1.29%

lifesciences device grant diabetes
ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2023 and Provide Corporate Update
Published: 2023-08-03 (Crawled : 20:00) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: 0.0% H: 4.2% C: 1.4%

lifesciences update financial results
ReShape Lifesciences® Signs Preferred Partner Agreement With Hive Medical for Lead Optimization Software
Published: 2023-06-29 (Crawled : 12:00) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: 1.42% H: 2.8% C: -2.1%

lifesciences software medical agreement
ReShape Lifesciences® Presents Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the ASMBS 2023 Annual Meeting
Published: 2023-06-28 (Crawled : 12:20) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: -1.32% H: 0.81% C: -5.37%

lifesciences device meeting diabetes
ReShape Lifesciences® Submits FDA PMA Supplement Application for the Next-Generation Lap-Band® 2.0
Published: 2023-06-26 (Crawled : 20:00) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: -8.57% H: 3.01% C: -5.63%

lifesciences fda application
ReShape Lifesciences® to Participate in Investor and Industry Conferences in June
Published: 2023-06-14 (Crawled : 12:00) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: 0.42% H: 0.0% C: -1.26%

lifesciences
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.